PMC:6640909 / 36389-36558 JSONTXT

Annnotations TAB JSON ListView MergeView

    TEST0

    {"project":"TEST0","denotations":[{"id":"31100109-9-16-7349","span":{"begin":165,"end":168},"obj":"[\"22727248\"]"}],"text":"Inhaled NO, epoprostenol (or prostacyclin) and phosphodiesterase 5 inhibitors may be considered to reduce right heart failure after LVAD implantation. IIb C [323–327]"}

    MyTest

    {"project":"MyTest","denotations":[{"id":"31100109-22727248-28905409","span":{"begin":165,"end":168},"obj":"22727248"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Inhaled NO, epoprostenol (or prostacyclin) and phosphodiesterase 5 inhibitors may be considered to reduce right heart failure after LVAD implantation. IIb C [323–327]"}

    0_colil

    {"project":"0_colil","denotations":[{"id":"31100109-22727248-7349","span":{"begin":165,"end":168},"obj":"22727248"}],"text":"Inhaled NO, epoprostenol (or prostacyclin) and phosphodiesterase 5 inhibitors may be considered to reduce right heart failure after LVAD implantation. IIb C [323–327]"}

    2_test

    {"project":"2_test","denotations":[{"id":"31100109-22727248-28905409","span":{"begin":165,"end":168},"obj":"22727248"}],"text":"Inhaled NO, epoprostenol (or prostacyclin) and phosphodiesterase 5 inhibitors may be considered to reduce right heart failure after LVAD implantation. IIb C [323–327]"}